Reduced expression of NCOR2 has been associated with disease aggressiveness in prostate cancer, and knockdown of NCOR2 in cell line models leads to neuroendocrine prostate cancer (NEPC) gene signatures.20 This evidence concerns the gene NCOR2 and Familial prostate cancer.